Geode Capital Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Geode Capital Management’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,274	Closed	-$696K	–	4885
2023 Q2	$696K	Buy	41,274 +16,627	+67%	+$219K	﹤0.01%	3493
2023 Q1	$212K	Buy	24,647 +1,593	+7%	+$13.1K	﹤0.01%	4018
2022 Q4	$198K	Hold	23,054	–	–	﹤0.01%	4111
2022 Q3	$138K	Hold	23,054	–	–	﹤0.01%	4402
2022 Q2	$124K	Hold	23,054	–	–	﹤0.01%	4498
2022 Q1	$108K	Hold	23,054	–	–	﹤0.01%	4637
2021 Q4	$113K	Buy	23,054 +5,274	+30%	+$26K	﹤0.01%	4695
2021 Q3	$137K	Hold	17,780	–	–	﹤0.01%	4579
2021 Q2	$207K	Buy	+17,780	New	+$270K	﹤0.01%	4332

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return

Geode Capital Management's VECT Position: Q3 2023 in Review

Geode Capital Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 41,274 shares — an estimated $696K sold.

Geode Capital Management first reported a position in VECT in Q2 2021 and held it in 9 quarters. The position peaked at $696K in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Geode Capital Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Geode Capital Management sold 41,274 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $696K.
Geode Capital Management first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 9 quarters.
Geode Capital Management's VectivBio Holding AG Ordinary Shares position peaked at $696K in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.